Comparison of the potency of the lipid II targeting antimicrobials nisin, lacticin 3147 and vancomycin against Gram positive bacteria Previous Bioengineered nisin derivatives with enhanced activity in complex matrices Read more Next Bioengineering; a bacteriocin perspective Read more